New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
15:43 EDTPGNX, LXU, SUSP, CCC, MHR, SSP, BECN, ESNT, HMSY, SUSS, PDCE, DRH, CHH, SRO, BPL, BAMNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Brookfield Asset Management (BAM), one estimate 31c; Buckeye Partners (BPL), consensus 84c; Sirona Dental (SRO), consensus 96c; Choice Hotels (CHH), consensus 49c; Diamondrock Hospitality (DRH), consensus 25c; PDC Energy (PDCE), consensus 34c; Susser Holdings (SUSS), consensus 93c; HMS Holdings (HMSY), consensus 12c; Essent Group (ESNT), consensus 21c; Beacon Roofing (BECN), consensus 58c; E. W. Scripps (SSP), consensus 12c; Magnum Hunter Resources (MHR), consensus (17c); Calgon Carbon (CCC), consensus 28c; Susser Petroleum (SUSP), consensus 54c; LSB Industries (LXU), consensus 78c; Progenics Pharmaceuticals (PGNX), consensus (14c).
News For BAM;BPL;SRO;CHH;DRH;PDCE;SUSS;HMSY;ESNT;BECN;SSP;MHR;CCC;SUSP;LXU;PGNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 28, 2014
09:32 EDTCCCCalgon Carbon second drinking water treatment contract in South Korea
Calgon Carbon announced that it has been awarded a contract by Samsung C&T Corporation to supply 7.2M pounds of Filtrasorb granular activated carbon, or GAC, to the Dduk-Do Municipal Drinking Water, or Dduk-Do, Plant in Seoul City, South Korea. The value of the contract was not disclosed. The Dduk-Do Plant provides 198M gallons of potable water daily to approximately one million residents in 7 districts including SeongDong-Gu, Seoul metropolitan area, South Korea. The GAC will be installed in newly constructed carbon filters to remove taste and odor from the plantís source water. Delivery of the carbon is expected to begin in December and be completed in the 2Q15.
October 27, 2014
10:00 EDTPDCEOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abraxas Petroleum (AXAS) downgraded to Hold from Buy at Stifel... Anadarko (APC) downgraded to Neutral from Buy at Goldman... Basic Energy (BAS) downgraded to Sell from Buy at Goldman... Cabot Oil & Gas (COG) downgraded to Sector Perform from Outperform at Howard Weil... Coca-Cola (KO) downgraded to Neutral from Buy at Buckingham... CommScope (COMM) downgraded at BofA/Merrill... Concho Resources (CXO) downgraded to Hold from Buy at Stifel... Consolidated Communications (CNSL) downgraded to Market Perform at Raymond James... Continental Resources (CLR) downgraded to Neutral from Buy at Goldman... Covanta (CVA) assumed with a Neutral from Outperform at Macquarie... DCP Midstream (DPM) downgraded to Neutral from Buy at Goldman... Denbury Resources (DNR) downgraded to Hold from Buy at Stifel... Diamond Offshore (DO) downgraded to Sell from Neutral at Goldman... Diana Shipping (DSX) downgraded to Hold from Buy at Deutsche Bank... EP Energy (EPE) downgraded to Neutral from Buy at Goldman... EZchip (EZCH) downgraded to Neutral from Buy at Chardan... Emerge Energy (EMES) downgraded to Neutral from Buy at Goldman... Encore Wire (WIRE) downgraded to Neutral from Buy at DA Davidson... Enduro Royalty Trust (NDRO) downgraded to Neutral from Buy at Goldman... First Niagara (FNFG) downgraded to Sector Perform from Outperform at RBC Capital... GOL Linhas (GOL) downgraded to Neutral from Buy at BofA/Merrill... Goodrich Petroleum (GDP) downgraded to Hold from Buy at Stifel... Halliburton (HAL) downgraded to Buy from Conviction Buy at Goldman... Home Loan Servicing (HLSS) downgraded to Neutral from Buy at Citigroup... ICON plc (ICLR) downgraded to Equal Weight from Overweight at Barclays... IHS Inc. (IHS) downgraded to Equal Weight from Overweight at Barclays... Jones Energy (JONE) downgraded to Hold from Buy at Stifel... Laredo Petroleum (LPI) downgraded to Sell from Neutral at Goldman... Lloyds Banking (LYG) downgraded to Underperform from Hold at Jefferies... Midcoast Energy (MEP) downgraded to Neutral from Buy at Goldman... PDC Energy (PDCE) downgraded to Hold from Buy at Stifel... PNC Financial (PNC) downgraded at Sterne Agee... Parsley Energy (PE) downgraded to Sell from Neutral at Goldman... Patterson-UTI (PTEN) downgraded to Neutral from Conviction Buy at Goldman... Pioneer Energy (PES) downgraded to Neutral from Buy at Goldman... Precision Castparts (PCP) downgraded at RBC Capital... Royal Gold (RGLD) downgraded to Neutral from Overweight at HSBC... SM Energy (SM) downgraded to Hold from Buy at Stifel... Sanchez Energy (SN) downgraded to Hold from Buy at Stifel... Scorpio Bulkers (SALT) downgraded to Hold from Buy at Deutsche Bank... Synergy Resources (SYRG) downgraded to Hold from Buy at Stifel... Ventas (VTR) downgraded to Neutral from Buy at UBS... Whiting Petroleum (WLL) downgraded to Hold from Buy at Stifel... Zumiez (ZUMZ) downgraded to Neutral from Buy at DA Davidson.
06:17 EDTPDCEPDC Energy downgraded to Hold from Buy at Stifel
Subscribe for More Information
October 24, 2014
13:57 EDTBAMBrookfield Residential downgraded to Market Perform at Wells Fargo
Wells Fargo downgraded Brookfield Residential (BRP) to Market Perform from Outperform citing the proposed acquisition by Brookfield Asset Management (BAM).
08:03 EDTCHHChoice Hotels sees FY14 EPS $1.99-$2.02, consensus $1.96
EBITDA for full-year 2014 are expected to range between $216 million and $219 million. The effective tax rate for continuing operations is expected to be 30.7% and 30.3% for the fourth quarter and full- year 2014, respectively. EBITDA from franchising activities for full-year 2014 are expected to range between $234 million and $237 million; Net domestic unit growth for 2014 is expected to range between 1% and 2%; RevPAR is expected to increase approximately 9% for the fourth quarter and range between 8% and 8.5% for full-year 2014; The effective royalty rate is expected to decline 5 basis points for full-year 2014 as compared to full-year 2013. Reductions in EBITDA relating to our investment in the SkyTouch division for full-year 2014 are expected to be approximately $18 million; Execution of third-party contracts results in annualized revenue ranging between $4 million and $6 million with realized revenues for the year ended December 31, 2014 totaling approximately $1 million; and SG&A expenses are forecasted to be approximately $19 million related to investment in business development, sales and marketing and non-capitalizable product development expenditures related to the division's cloud-based hotel operating system's technology related products and services.
08:02 EDTCHHChoice Hotels sees Q4 EPS 34c, consensus 38c
08:01 EDTCHHChoice Hotels reports Q3 Franchising revenue $99.4M
Subscribe for More Information
08:01 EDTCHHChoice Hotels reports Q3 EPS cont ops 67c, consensus 63c
Reports Q3 revenue $215.17M, consensus $228.04M
October 23, 2014
08:12 EDTBAMBrookfield Residential to review Brookfield proposal
Subscribe for More Information
07:04 EDTBAMBrookfield proposes to acquire 30% of BRP not owned for $32.00 per share
Subscribe for More Information
October 21, 2014
17:13 EDTSUSPSusser Petroleum 8M share Secondary priced at $46.25
Morgan Stanley, BofA/Merrill, Barclays, Citigroup, Credit Suisse, Deutsche Bank, Goldman, Jefferies, JPMorgan, RBC Capital, UBS and Wells Fargo acted as joint book running managers for the offering.
09:03 EDTHMSYMagellan Health selects HMS unit for cost containment solutions
HMS, a wholly owned subsidiary of HMS Holdings (HMSY), announced that Magellan Health (MGLN) has selected HMS for cost containment solutions, including fraud, waste, and abuse detection and prevention across the company, as well as for insurance verification and subrogation services for Magellan Complete Care of Florida.
07:23 EDTSUSPSusser Petroleum files to sell 8M common units
Subscribe for More Information
October 20, 2014
08:19 EDTPGNXProgenics presents data from Phase 2 trial of 1404 PSMA imaging agent
Progenics Pharmaceuticals announced that data from a Phase 2 trial of its PSMA imaging agent candidate, 1404, have been presented at the 27th Annual European Association of Nuclear Medicine Congress being held in Gothenburg, Sweden. 1404 is a targeted small molecule designed to "visualize" prostate cancer by targeting prostate specific membrane antigen. "The Phase 2 data are quite impressive and demonstrate how SPECT/CT with 1404 may provide a more accurate assessment of the presence, location and extent of prostate cancer," said Dr. Dabasi. Gabriella Dabasi, Ph.D. presented, "1404 may provide prognostic information for both primary and metastatic disease in a single procedure, which could greatly enhance the clinical decision-making process. There is a strong rationale for continued development of this promising molecular imaging agent." In the Phase 2 trial, SPECT/CT imaging with 1404 showed 94% sensitivity in detecting and imaging cancer in the prostate gland of high-risk patients prior to prostatectomy. In addition, 1404 was more sensitive than MRI in detecting primary prostate cancer and was a good predictor of lymph node involvement at prostatectomy. SPECT/CT imaging with 1404 identified 14 more patients with suspicious lymph node sites than MRI. Uptake of 1404 in the lobes of the prostate gland showed a highly significant correlation with Gleason score. The data also showed uptake of 1404 in the primary tumor was significantly lower in treated patient, corresponding to a decrease in PSA over time observed in these treated patients.
October 17, 2014
10:00 EDTPDCEOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AK Steel (AKS) upgraded to Buy from Neutral at Nomura... AMD (AMD) upgraded to Sector Perform from Underperform at Pacific Crest... Atlantic Power (AT) upgraded to Market Perform from Underperform at BMO Capital... Basic Energy (BAS) upgraded to Outperform from Market Perform at Cowen... BorgWarner (BWA) upgraded to Buy from Hold at Deutsche Bank... CA Technologies (CA) upgraded to Overweight from Equal Weight at Barclays... Calumet Specialty Products (CLMT) upgraded to Outperform at Wells Fargo... DHT Holdings (DHT) upgraded to Buy from Hold at Evercore... Exelon (EXC) upgraded to Neutral from Sell at Citigroup... Fifth Third Bancorp (FITB) upgraded to Buy from Neutral at Citigroup... Goldman Sachs (GS) upgraded to Outperform from Market Perform at Keefe Bruyette... Helmerich & Payne (HP) upgraded to Buy from Neutral at UBS... Hilton (HLT) upgraded to Buy from Neutral at SunTrust... Hyatt Hotels (H) upgraded to Outperform from Neutral at Macquarie... IPG Photonics (IPGP) upgraded at Stifel... ITC Holdings (ITC) upgraded to Neutral from Underperform at Credit Suisse... Manpower (MAN) upgraded to Outperform from Market Perform at Avondale... Nabors Industries (NBR) upgraded to Outperform from Market Perform at Cowen... Newpark Resources (NR) upgraded at Cowen... Old Dominion (ODFL) upgraded to Buy from Neutral at Longbow... PDC Energy (PDCE) upgraded at SunTrust... Patterson-UTI (PTEN) upgraded to Buy from Neutral at UBS... PrivateBancorp (PVTB) upgraded to Outperform from Neutral at Macquarie... QLogic (QLGC) upgraded to Buy from Hold at Summit Research... RPC, Inc. (RES) upgraded at Cowen... Sonoco (SON) upgraded to Neutral from Underperform at DA Davidson... Southwestern Energy (SWN) upgraded to Outperform from Market Perform at Raymond James... SunEdison (SUNE) upgraded to Outperform at Cowen... TSMC (TSM) upgraded to Buy from Neutral at Mizuho... Tesco (TESO) upgraded to Outperform from Market Perform at Cowen... UnitedHealth (UNH) upgraded to Outperform from Market Perform at Leerink... Xilinx (XLNX) upgraded to Outperform from Market Perform at Wells Fargo.
07:48 EDTPDCEPDC Energy upgraded at SunTrust
As previously reported, SunTrust upgraded PDC Energy to Buy from Neutral. The firm upgraded shares based on relative valuation, expectations for more well results and a strong program out of Utica, and potential data from the Wattenberg field. Price target lowered to $57 from $67.
06:45 EDTPDCEPDC Energy upgraded to Buy from Neutral at SunTrust
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use